{
    "organizations": [],
    "uuid": "b8d87ce4eb438686b0eea783010d924c2ea3ed73",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-swedish-drug-maker-isr-to-launch-p/brief-swedish-drug-maker-isr-to-launch-phase-iia-study-idUSFWN1P710Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Swedish drug maker ISR to launch phase IIa study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 12 (Reuters) - Isr Immune System Regulation Holding Ab (Publ):\n* SWEDISH REGULATOR APPROVES Q1 LAUNCH OF PHASE IIA STUDY‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-13T00:34:00.000+02:00",
    "crawled": "2018-01-13T14:36:09.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "isr",
        "immune",
        "system",
        "regulation",
        "holding",
        "ab",
        "publ",
        "swedish",
        "regulator",
        "approves",
        "q1",
        "launch",
        "phase",
        "iia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}